GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (SSE:4502) » Definitions » 12-1 Month Momentum %

Takeda Pharmaceutical Co (SSE:4502) 12-1 Month Momentum % : 0.70% (As of Apr. 27, 2024)


View and export this data going back to . Start your Free Trial

What is Takeda Pharmaceutical Co 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-27), Takeda Pharmaceutical Co's 12-1 Month Momentum % is 0.70%.

The industry rank for Takeda Pharmaceutical Co's 12-1 Month Momentum % or its related term are showing as below:

SSE:4502's 12-1 Month Momentum % is ranked better than
52.88% of 1112 companies
in the Drug Manufacturers industry
Industry Median: -5.73 vs SSE:4502: 0.70

Competitive Comparison of Takeda Pharmaceutical Co's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takeda Pharmaceutical Co's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's 12-1 Month Momentum % falls into.



Takeda Pharmaceutical Co  (SSE:4502) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Takeda Pharmaceutical Co  (SSE:4502) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Takeda Pharmaceutical Co 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Takeda Pharmaceutical Co (SSE:4502) Business Description

Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co (SSE:4502) Headlines

No Headlines